2017
DOI: 10.4172/pharmaceutical-sciences.1000214
|View full text |Cite
|
Sign up to set email alerts
|

Urolithiasis: An Update on Diagnostic Modalities and Treatment Protocols

Abstract: Sweta, et al.: Diagnosis and Treatment of UrolithiasisUrolithiasis or urinary stone disease is a ubiquitous affliction that spares no geographical region or demographic. Plenty of research is being carried out in quest for mitigating this disease condition. However, any detailed information that could impart knowledge on all the major aspects of the subject in an unfractionated form is still deficient. This review is an attempt to revive the existing knowledge on urolithiasis, basically focused on its diagnosi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 104 publications
(175 reference statements)
0
10
0
2
Order By: Relevance
“…High recurrence rate of urolithiasis mounting to over 50% relapses in 5–10 years is exacerbating [3] . Moreover, benefits from a plethora of urological interventions available for the treatment of urinary stone disease ranging from medical expulsive therapy to extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy are compromised due to associated complications [4] and tendency to promote recurrence [5] . These treatment options for urolithiasis have emerged as one of the major contributors of chronic kidney disease [6] .…”
Section: Introductionmentioning
confidence: 99%
“…High recurrence rate of urolithiasis mounting to over 50% relapses in 5–10 years is exacerbating [3] . Moreover, benefits from a plethora of urological interventions available for the treatment of urinary stone disease ranging from medical expulsive therapy to extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy are compromised due to associated complications [4] and tendency to promote recurrence [5] . These treatment options for urolithiasis have emerged as one of the major contributors of chronic kidney disease [6] .…”
Section: Introductionmentioning
confidence: 99%
“…Results of Phytochemical screening [14]. Therefore, the anti-crystallization, anti aggregatory and crystal growth defying activity of the plants would have been an…”
Section: Resultsmentioning
confidence: 99%
“…Однако следует учитывать, что у 85% пациентов, принимающих D-пеницилламин, возникают значительные побочные эффекты, и около 70% в конечном итоге прекращают его принимать [106]. Альфа-меркаптопропионилглицин (или тиопронин) является лучше переносимой альтернативой D-пеницилламину, но его эффективность и доступность намного ниже по сравнению с D-пеницилламином [107]. Считается, что максимальная концентрация цистина в моче обнаруживается ночью, поэтому важны прием жидкости и хелатная терапия перед сном [108].…”
Section: цистиновые камниunclassified